Monte Rosa holds KOL webinar on MRT-2359 hosted by Cowen on Oct 24, 2022

Monte Rosa Therapeutics, Inc.

Presented at KOL webinar hosted by Cowen on MRT-2359, a targeted protein degrader.
Guest speakers included Jordi Rodon Ahnert (MD Anderson) and Davide Ruggero (UCSF).
No specific clinical or financial data disclosed in the filing or exhibit.

item 7.01 item 9.01

Monte Rosa Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-267232

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.